Will Higgins is an industry expert with over 15 years of experience spanning a range of company sizes and disciplines. Will spent a decade working in small molecule drug development at Merck, Eli Lilly, and Johnson & Johnson, in addition to 5 years developing complex, bioengineered tissues for both in vitro and clinical applications at 3D bioprinting pioneer, Organovo. Kidney research has been a core theme of his career with 10+ years spent interrogating renal clearance mechanisms to both predict and explain pharmacokinetic profiles, as well as the development of bioengineered kidney tissues derived from both primary and stem cell sources. Stemming from this research, Will is an author on 14 publications which have generated over 750 citations. In addition to his research experience, Will has successfully mentored junior staff, managed external collaborations, and facilitated the transfer of complex technical processes between collaborative organizations to drive innovation. Will received his bachelor’s and master’s degrees in biotechnology from The Pennsylvania State University.